Sequence Detail

ID/Version

Q8R0V5 E9QKA9 A4UHF3 (UniProt | EBI)

Last sequence update: 2015-10-14
Last annotation update: 2024-07-24

Sequence description from provider

RecName: Full=Indoleamine 2,3-dioxygenase 2 {ECO:0000305|PubMed:17671174}; Short=IDO-2 {ECO:0000303|PubMed:17671174}; EC=1.13.11.- {ECO:0000269|PubMed:17499941, ECO:0000269|PubMed:17671174};AltName: Full=Indoleamine 2,3-dioxygenase-like pr

Provider

SWISS-PROT

Sequence

Polypeptide 405 aa

Source

Organism mouse

See UniProt | EBI for source

Annotated genes and markers

Follow the symbol links to get more information on the GO terms, expression assays, orthologs, phenotypic alleles, and other information for the genes or markers below.

Type	Symbol	Name	GO Terms	Expression Assays	Orthologs	Phenotypic Alleles
Gene	Ido2	indoleamine 2,3-dioxygenase 2	16	100	3	13

Sequence references in MGI

J:121983 Ball HJ, et al., Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene. 2007 Jul 1;396(1):203-13
J:123879 Metz R, et al., Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007 Aug 1;67(15):7082-7
J:211949 Metz R, et al., IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int Immunol. 2014 Jul;26(7):357-67
J:292518 Huttlin EL, et al., A tissue-specific atlas of mouse protein phosphorylation and expression. Cell. 2010 Dec 23;143(7):1174-89